Study reports encouraging response rates, and data support safety and preliminary proof of mechanism 10 December, 2012.
http://www.drugs.com/clinical_trials/adaptimmune-announces-preliminary-results-early-phase-trial-gene-engineered-t-cells-targeting-14848.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29
http://www.drugs.com/clinical_trials/adaptimmune-announces-preliminary-results-early-phase-trial-gene-engineered-t-cells-targeting-14848.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+Drugscom-ClinicalTrials+%28Drugs.com+-+Clinical+Trials%29
No comments:
Post a Comment